Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-744

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 20 mg (71610 0744 15)

Bottle Label 20 mg (71610 0744 15)
FDA Label Image

Bottle Label 40 mg (71610 0745 15)

Bottle Label 40 mg (71610 0745 15)
FDA Label Image

Bottle Label 80 mg (71610 0746 15)

Bottle Label 80 mg (71610 0746 15)
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This text appears to be a statistical report showing cumulative incidence and hazard ratio values. The cumulative incidence is represented by percentages at different time points (15, 20, 25, 30, 35 years). The hazard ratio (HR) is given as 0.64, with a confidence interval of 0.50 to 0.83, and a p-value of 0.0005. This information suggests that there may be a significant association between the observed event and the risk factor being studied.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
This text appears to represent the results of a cumulative hazard analysis for a study comparing the effects of a placebo and the medication atorvastatin. The cumulative hazard percentages at 15 and 10 are given. There is also information about the hazard ratio (HR) of 0.63 (with a 95% confidence interval of 0.48-0.83) and a p-value of 0.001. The text also indicates that the study measured the time to the first primary endpoint over a period of four years. However, due to the limited information provided and potential errors, the full context and interpretation of the results cannot be determined.*
FDA Label Image

Figure-03 (Figure 3)

Figure-03 (Figure 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.